FAP and cancer: FAP is a type II transmembrane serine protease, almost exclusively expressed in pathological conditions such as fibrosis, arthritis, and cancer, which was first identified in cultured fibroblasts by Wolfgang Rettig in 1986 and described as a cell surface antigen.